Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01838395 |
| Title | Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | BioLineRx, Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ISR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic | Jacksonville | Florida | 32224 | United States | Details | |
| Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21231 | United States | Details | |
| Washington University School of Medicine | Saint Louis | Missouri | 63110 | United States | Details | |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Rambam Medical Center | Haifa | 31096 | Israel | Details | ||
| Shaare Zedek Medical Center | Jerusalem | 91031 | Israel | Details | ||
| Meir Medical Center | Kfar Saba | Israel | Details | |||
| Chaim Sheba Medical Center | Ramat Gan | 52621 | Israel | Details | ||
| Tel-Aviv Sourasky Medical Center | Tel Aviv | 64239 | Israel | Details |